Oklahoma AG announces 4 new opioid settlements worth $226M
Oklahoma has entered into four new settlements with opioid makers and distributors totaling more than $226 million
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Oklahoma entered settlement agreements with three major pharmacy chains and an opioid manufacturer totaling more than $226 million, Attorney General John O'Connor announced Wednesday.
Including the new settlements with drugmaker Allergan and pharmacy chains CVS, Walgreens and Walmart, Oklahoma has received more than $900 million from opioid makers and distributors to help address the state's opioid crisis, O'Connor said.
“The opioid crisis has inflicted unspeakable pain on Oklahoma families and caused the deaths of thousands of Oklahomans,” O'Connor said in a statement. “Between 2016 and 2020, more than 3,000 Oklahomans died from opioid overdoses."
Nearly all the settlement funds must be used to help remediate the affects of the opioid crisis in Oklahoma, including prevention and treatment services.
In November, three of the largest U.S. pharmacy chains reached settlements with states over the toll of opioids worth a total of about $13 billion. Under the separate deals, CVS Health and Walgreen Co. are each paying about $5 billion and Walmart is paying more than $3 billion. None has admitted wrongdoing.
Allergan didn't immediately respond to a message seeking comment about the Oklahoma settlement.
The settlements are the latest in a wave of deals that state and local governments have struck with companies, including drugmakers, distribution companies and even a consulting firm, even as some lawsuits over how the drugs are marketed and sold continue. The total of proposed and finalized settlements is now more than $50 billion. Unlike with tobacco company settlements in the 1990s, the bulk of the money is required to be used to address the opioid crisis, which has been linked to well over 500,000 U.S. deaths since 2000.
In 2019, Oklahoma, under then-Attorney General Mike Hunter, was the first state to reach a settlement with Purdue Pharma, the maker of OxyContin, for $270 million. Most of that money was used to establish a National Center for Addiction Studies and Treatment at Oklahoma State University in Tulsa.
Oklahoma was also the first state to go to trial in a lawsuit against the makers of opioids blamed for contributing to the nation's opioid crisis. A district court judge in 2019 found that New Jersey-based drugmaker Johnson & Johnson and its Belgium-based subsidiary Janssen Pharmaceuticals violated the state's public nuisance statute and ultimately ordered the company to pay the state $465 million to help address the state's opioid crisis. However that decision was later overturned by the state's Supreme Court, which determined the trial court judge wrongly interpreted the state's public nuisance law.
___
Follow Sean Murphy at www.twitter.com/apseanmurphy